Baillie Gifford & Co - Dec 31, 2024 SCHEDULE 13G/A Report for RECURSION PHARMACEUTICALS, INC. Common Stock (DNA)

Filing Manager: Baillie Gifford & Co
Reporting Manager: BAILLIE GIFFORD & CO
Security: RECURSION PHARMACEUTICALS, INC. Common Stock
Symbol: DNA
Shares outstanding: 383M shares
Disclosed Ownership: 24.9M shares
Ownership: 6.5%
Form type: SCHEDULE 13G/A
Date filed: 2/12/2025, 09:32 AM
Date of event: Dec 31, 2024
Previous filing: Nov 4, 2024
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
BAILLIE GIFFORD & CO	6.5%	24.9M	24.8M	0	Grant Meikle	Threshold & Transaction Reporting Manager